Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ALF-ACUTE: Alfuzosin in BPH
NCT00540891Phase 3Completed
- Sponsor
- Sanofi
- Start
- Feb 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of alfuzosin in benign prostatic hyperplasia (BPH), sponsored by Sanofi. Started Feb 2003; status: completed.
02
Drugs
alfuzosin
03
Conditions
benign prostatic hyperplasia (BPH)
Beyond the preview
Go deeper on NCT00540891.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00540891.